In line, MFN2, OPA1, or DRP1 deficiency negatively affect muscle health and mitochondrial homeostasis, triggering the insurgence of sarcopenia features, such as muscle atrophy [68,69,70]. This evidence concerns the gene MFN2 and sarcopenia.